- After a Medicare payment policy related to dialysis was implemented in 2011, use of home-based peritoneal dialysis increased significantly.
- Increases were seen for both “early” and “late” peritoneal dialysis: more patients initiated dialysis with peritoneal dialysis and more patients switched from hemodialysis to peritoneal dialysis.
Home-based peritoneal dialysis offers a number of benefits over traditional hemodialysis performed several times a week in dialysis clinics. These include greater satisfaction of patients with treatment and lower costs to society. Despite these apparent benefits, the use of peritoneal dialysis in the United States has traditionally been low.
In 2011, Medicare implemented a comprehensive payment policy that makes a single payment for all dialysis treatments, medications, and ancillary services for patients with kidney failure. To assess whether this policy has affected the use of peritoneal dialysis, a team led by Virginia Wang, PhD MSPH (Duke University School of Medicine and Durham Veterans Affairs Health Care System) retrieved information on all US patients initiating dialysis before (2006–2010) and after (2011–2013) the policy was implemented.
Overall, 619,126 patients with kidney failure initiated dialysis from 2006–2013. Comparing before and after the policy was implemented, early use of peritoneal dialysis increased from 9.4% of patients to 12.6% of patients. Late use of peritoneal dialysis (4 months to 2 years after any form of dialysis was initiated) increased from 12.1% to 16.1%. “In this later-term category, we found a notable increase in the rates of patients switching from hemodialysis to peritoneal dialysis,” said Dr. Wang. “These findings provide a more complete and nuanced understanding of the effects of Medicare’s payment policy and identify potential targets for policy refinement and practice changes.”
Study co-authors include Caroline E. Sloan, MD, Cynthia J. Coffman, PhD, Linda L. Sanders, MPH, Matthew L. Maciejewski, PhD, Shoou-Yih D. Lee, PhD, and Richard A. Hirth, PhD.
Disclosures: Dr. Coffman, Ms. Sanders, Dr. Maciejewski, Dr. Lee, Dr. Hirth, and Dr. Wang were supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R01DK097165). Dr. Sloan was supported by a Department of Veterans Affairs Office of Academic Affiliation post-doctoral fellowship. Dr. Coffmann, Dr. Maciejewski, and Dr. Wang report receiving grant funding from Department of Veterans Affairs Health Services Research and Development Service (Maciejewski-RCS 10-391) and the Durham Center of Innovation to Accelerate Discovery & Practice Transformation (ADAPT), (CIN 13-410) at the Durham VA Health Care System outside of the submitted work. Dr. Maciejewski reports stock ownership in Amgen due to his spouse’s employment. Dr. Coffman, Dr. Hirth, Dr. Lee, Dr. Maciejewski, and Dr. Wang report receiving funding from the National Institutes of Health outside of the submitted work. Ms. Sanders reports no relationship or financial interest with any entity that would pose a conflict of interest regarding the subject matter of this article.
The article, entitled “Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform,” will appear online at http://cjasn.asnjournals.org/ on November 21, 2019, doi: 10.2215/CJN.05910519.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit www.asn-online.org or contact the society at 202-640-4660.
The content of this news release is solely the responsibility of the authors and does not necessarily represent the official views or imply endorsement of the National Institutes of Health.
# # #
Original post https://alertarticles.info